PTEN and breast cancer: Several genetically modified mouse strains have been generated to model the role of the PI3K/AKT pathway in breast cancer, including mammary-specific knockout of PTEN [47], mammary-specific expression of mutant PIK3CA, or myristoylated AKT1 [48].